Cahigas, Archelie T.
HRN: 21-74-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2022
CEFUROXIME 1.5GM (VIAL)
08/06/2022
08/13/2022
IV
1.5g
Q8
CAP MR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes